Men with low-risk prostate cancer may wait to see if their disease progresses before treating it, an independent panel of experts convened by the U.S. National Institutes of Health (NIH) said on Wednesday.
Although this is almost 'common knowledge' these days, it's nice to see the NIH adding it's weight to the argument.
Read the full article here:
Some men can delay prostate cancer treatment
